Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Family Therapy01:30

Family Therapy

615
Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
615
Protein Families02:47

Protein Families

17.2K
Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K
Protein Families02:47

Protein Families

4.5K
4.5K
Gene Families01:57

Gene Families

10.0K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.9K
3.9K
Sources of Self-Esteem I: Family Experience01:18

Sources of Self-Esteem I: Family Experience

197
Self-esteem, a crucial component of psychological development, is significantly shaped by familial experiences. The early parent-child relationship serves as a foundational influence on a child's self-concept, with long-lasting effects extending into adolescence and adulthood.Parental Behaviors and Early Self-Esteem FormationEmpirical studies have identified four principal parental behaviors that foster healthy self-esteem in children. These include expressions of acceptance, affection, and...
197

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Expanding Oral Options for LDL Cholesterol Management: Ain't No Cholesterol High Enough, Ain't No Target Low Enough!

Journal of the American College of Cardiology·2026
Same author

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Atherosclerosis·2026
Same author

In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for Hypercholesterolemia.

The New England journal of medicine·2026
Same author

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

European journal of preventive cardiology·2026
Same author

Temporal Trends in Lipid-Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery Disease.

Journal of the American Heart Association·2026
Same author

Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial.

Nature medicine·2026
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.5K

Advanced therapy in familial hypercholesterolemia.

Edward Gao, Liam R Brunham, Ran D Goldman

    Canadian Family Physician Medecin De Famille Canadien
    |February 12, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Familial hypercholesterolemia (FH) requires early diagnosis and treatment. For children with FH unresponsive to statins, advanced therapies like PCSK9 and ANGPTL3 inhibitors offer potential cardiovascular benefits, though more pediatric research is needed.

    More Related Videos

    Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
    21:55

    Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

    Published on: April 2, 2012

    29.2K
    Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
    11:12

    Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

    Published on: September 13, 2024

    970

    Related Experiment Videos

    Last Updated: Feb 14, 2026

    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
    10:56

    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

    Published on: September 15, 2018

    8.5K
    Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
    21:55

    Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

    Published on: April 2, 2012

    29.2K
    Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
    11:12

    Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

    Published on: September 13, 2024

    970

    Area of Science:

    • Cardiology
    • Genetics
    • Pediatrics

    Background:

    • Familial hypercholesterolemia (FH) is a genetic disorder leading to significantly elevated LDL-C levels.
    • Children with FH face an increased risk of early-onset atherosclerosis and cardiovascular disease.

    Purpose of the Study:

    • To review current recommendations for diagnosing and treating pediatric FH.
    • To assess the safety and efficacy of advanced therapies for children with FH.
    • To explore strategies for managing elevated LDL-C in pediatric patients.

    Main Methods:

    • Literature review of current guidelines and clinical studies on FH management in children.
    • Analysis of data on the efficacy and safety of statins, monoclonal antibodies, PCSK9 inhibitors, and ANGPTL3 inhibitors in pediatric populations.
    • Focus on treatment outcomes for patients with homozygous and heterozygous FH.

    Main Results:

    • High-intensity statin therapy may be insufficient for some pediatric FH patients.
    • Monoclonal antibodies, PCSK9 inhibitors (e.g., evolocumab), and ANGPTL3 inhibitors (e.g., evinacumab) show promise as adjunct treatments.
    • Evinacumab demonstrated higher efficacy than evolocumab in limited pediatric studies for homozygous FH.

    Conclusions:

    • Early diagnosis and specialist consultation are crucial for children with FH.
    • Advanced therapies like PCSK9 and ANGPTL3 inhibitors can significantly reduce LDL-C when statins are inadequate.
    • Further long-term research on novel therapies in pediatric FH is essential to confirm safety and efficacy.